Topics

”Den viktigaste milstolpen hittills”

07:45 EDT 26 Mar 2020 | Lifescience Sweden

Oncopeptides presenterar resultat från fas II-studien Horizon – Planerar NDA-ansökan.

Original Article: ”Den viktigaste milstolpen hittills”

NEXT ARTICLE

More From BioPortfolio on "”Den viktigaste milstolpen hittills”"

Quick Search